stella
beta
Hyperkalemia Quality Improvement Program (HK-QIP) Study — Stella
Home
/
Hyperkalemia
/
Hyperkalemia Quality Improvement Program (HK-QIP) Study
View on ClinicalTrials.gov
Recruiting
Back to Hyperkalemia trials
Hyperkalemia Quality Improvement Program (HK-QIP) Study
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(49 sites)
China
Research Site, Beijing
Research Site, Benxi
Research Site, Changchun
Research Site, Changsha
Research Site, Changsha
Research Site, Changsha
Research Site, Chengdu
Research Site, Chengdu
Research Site, Chengdu
Research Site, Chongqing
Research Site, Dalian
Research Site, Fuyang
Research Site, Fuzhou
Research Site, Fuzhou
Research Site, Gejiu
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Guiyang
Research Site, Haikou
Research Site, Hangzhou
Research Site, Hefei
Research Site, Hohhot
Research Site, Jinan
Research Site, Jinan
Research Site, Kunming
Research Site, Kunming
Research Site, Lanzhou
Research Site, Nanchang
Research Site, Nanning
Research Site, Nantong
Research Site, Ningbo
Research Site, Pingdingshan
Research Site, Qiqihar
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shenyang
Research Site, Shijiazhuang
Research Site, Taiyuan
Research Site, Tianjin
Research Site, Ürümqi
Research Site, Wuhan
Research Site, Wuhu
Research Site, Wuxi
Research Site, Xi'an
Research Site, Xining
Research Site, Xinxiang
Research Site, Yinchuan
Research Site, Zhengzhou